ERBB2 and breast carcinoma: It was recently noted in a study looking at the bio-distribution of a T-cell dependent bi-specific antibody in a murine model of human HER2 breast cancer that the binding affinity for the white cell can determine whether or not the bi-specific antibody/white cell combination can reach the target site or becomes trapped in lymphatic organs (Mandikian et al. 2018).